CC
Commodore Capital LP disclosed a 7.6% stake in SGMT
Commodore Capital LP reported owning 7.6% of Sagimet Biosciences Inc. (SGMT) (5,507,752 shares) in a Schedule 13G filed Oct 7, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 7, 2026
- Source
- Schedule 13G